Synchron’s foundational technology, a motor neuroprosthesis, or motor BCI, is implanted via the jugular vein using neurointerventional techniques commonly used to treat stroke, and does not require ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Synchron has cemented its position as the frontrunner in brain computer interface (BCI) clinical trials, after the company reported positive 12-month safety and efficacy data for its Stentrode device.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Even though brain-computer interfaces (BCIs) are still an emerging part of neurotechnology, Neuralink, Elon Musk's BCI startup, has dominated headlines about the space. But rival company Synchron is ...

Please provide your email address to receive an email when new articles are posted on . Synchron’s brain-computer interface is implanted in a blood vessel on the surface of the motor cortex of the ...